SPG11 Antikörper (AA 2019-2318) (FITC)
-
- Target Alle SPG11 Antikörper anzeigen
- SPG11 (Spastic Paraplegia 11 (Autosomal Recessive) (SPG11))
-
Bindungsspezifität
- AA 2019-2318
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPG11 Antikörper ist konjugiert mit FITC
- Applikation
- Bitte anfragen
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Spatacsin protein (2019-2318AA)
- Isotyp
- IgG
- Top Product
- Discover our top product SPG11 Primärantikörper
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- SPG11 (Spastic Paraplegia 11 (Autosomal Recessive) (SPG11))
- Andere Bezeichnung
- SPG11 (SPG11 Produkte)
- Hintergrund
-
Background: cytoplasm, cytoplasmic vesicle, extracellular exosome, lysosomal membrane, nucleolus, plasma membrane
Aliases: Colorectal carcinoma associated protein antibody, Colorectal carcinoma-associated protein antibody, DKFZp762B1512 antibody, FLJ21439 antibody, KIAA1840 antibody, Spastic paraplegia 11 (autosomal recessive) antibody, Spastic paraplegia 11 antibody, Spastic paraplegia 11 protein antibody, Spatacsin antibody, SPG 11 antibody, Spg11 antibody, SPTCS_HUMAN antibody
- UniProt
- Q96JI7
-